Annual EBITDA
$7.70B$163.00M+2.16%
Summary
- Current Value
- As of today, DHR annual EBITDA is $7.70B, up +2.16% on
- Historical Performance
- DHR annual EBITDA is down -20.37% over the past 3 years, up +26.48% over the past 5 years
- All-Time High Comparison
- DHR annual EBITDA is currently -24.65% below its historical high of $10.22B set on
- 3-Year Low Comparison
- DHR annual EBITDA is +3.41% above its 3-year low of $7.45B reached on
- Sector Comparison
- DHR annual EBITDA is higher than 98.19% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $7.70B | +2.2% | -20.4% | +26.5% | +192.7% | |
| Quarterly EBITDA | $2.13B | -9.2% | -14.0% | +0.7% | +181.0% | |
| TTM EBITDA | $7.69B | +2.0% | -27.0% | +27.5% | +192.1% | |
| Price | $210.64 | +2.4% | -4.2% | +8.2% | +520.5% | |
| PE Ratio | 41.70 | +7.2% | +82.7% | +4.4% | +223.8% | |
| Annual Revenue | $24.57B | +2.9% | -7.8% | +10.3% | +86.1% | |
| Annual EPS | $5.05 | -4.6% | -47.6% | +3.3% | +91.2% | |
| Annual EBIT | $4.69B | -9.5% | -37.8% | +8.8% | +110.0% | |
| Annual Net Income | $3.60B | -7.7% | -43.1% | -1.3% | +100.8% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.67B | N/A | -20.4% |
| 5Y | $10.22B | -24.6% | |
| All | $10.22B | -24.6% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $7.45B | +3.4% | |
| 5Y | $6.09B | N/A | +26.5% |
| All | -$36.78M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of DHR?
As of today, DHR annual EBITDA is $7.70B
What is 1-year change in DHR annual EBITDA?
DHR annual EBITDA is up +2.16% year-over-year
What is 3-year change in DHR annual EBITDA?
DHR annual EBITDA is down -20.37% over the past 3 years
How far is DHR annual EBITDA from its all-time high?
DHR annual EBITDA is currently -24.65% below its historical high of $10.22B set on December 31, 2021
How does DHR annual EBITDA rank versus sector peers?
DHR annual EBITDA is higher than 98.19% of companies in Healthcare sector
When is DHR next annual earnings release?
As of today, the next annual earnings release for DHR has not been scheduled
Quarterly EBITDA
$2.13B$248.00M+13.21%
Summary
- Current Value
- As of today, DHR quarterly EBITDA is $2.13B, up +13.21% on
- Historical Performance
- DHR quarterly EBITDA is down -9.23% year-over-year, down -14.04% over the past 3 years
- All-Time High Comparison
- DHR quarterly EBITDA is currently -22.92% below its historical high of $2.76B set on
- 3-Year Low Comparison
- DHR quarterly EBITDA is +37.19% above its 3-year low of $1.55B reached on
- Sector Comparison
- DHR quarterly EBITDA is higher than 98.17% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $2.13B | +13.2% | -9.2% | -14.0% | +0.7% | |
| Annual EBITDA | $7.70B | – | +2.2% | -20.4% | +26.5% | |
| TTM EBITDA | $7.69B | -2.7% | +2.0% | -27.0% | +27.5% | |
| Price | $210.64 | -7.8% | +2.4% | -4.2% | +8.2% | |
| PE Ratio | 41.70 | -11.3% | +7.2% | +82.7% | +4.4% | |
| Quarterly Revenue | $6.84B | +13.0% | +4.6% | -4.2% | +1.1% | |
| Quarterly EPS | $1.68 | +32.3% | +12.9% | -43.2% | +1.7% | |
| Quarterly EBIT | $1.50B | +19.7% | -14.0% | -24.8% | -6.2% | |
| Quarterly Net Income | $1.18B | +30.3% | +8.9% | -41.2% | -4.7% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.34B | N/A | -9.2% |
| 3Y | $2.47B | N/A | -14.0% |
| 5Y | $2.76B | -22.9% | |
| All | $2.76B | -22.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.80B | +17.9% | |
| 3Y | $1.55B | +37.2% | |
| 5Y | $1.55B | +37.2% | |
| All | -$483.80M | +539.2% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of DHR?
As of today, DHR quarterly EBITDA is $2.13B
What is DHR quarterly EBITDA most recent change?
DHR quarterly EBITDA was up +13.21% on December 31, 2025
What is 1-year change in DHR quarterly EBITDA?
DHR quarterly EBITDA is down -9.23% year-over-year
How far is DHR quarterly EBITDA from its all-time high?
DHR quarterly EBITDA is currently -22.92% below its historical high of $2.76B set on June 1, 2022
How does DHR quarterly EBITDA rank versus sector peers?
DHR quarterly EBITDA is higher than 98.17% of companies in Healthcare sector
When is DHR next earnings release?
The next earnings release for DHR is on
TTM EBITDA
$7.69B$216.00M-2.73%
Summary
- Current Value
- As of today, DHR TTM EBITDA is $7.69B, down -2.73% on
- Historical Performance
- DHR TTM EBITDA is up +1.98% year-over-year, down -26.96% over the past 3 years
- All-Time High Comparison
- DHR TTM EBITDA is currently -28.78% below its historical high of $10.79B set on
- 3-Year Low Comparison
- DHR TTM EBITDA is +8.21% above its 3-year low of $7.10B reached on
- Sector Comparison
- DHR TTM EBITDA is higher than 98.07% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $7.69B | -2.7% | +2.0% | -27.0% | +27.5% | |
| Annual EBITDA | $7.70B | – | +2.2% | -20.4% | +26.5% | |
| Quarterly EBITDA | $2.13B | +13.2% | -9.2% | -14.0% | +0.7% | |
| Price | $210.64 | -7.8% | +2.4% | -4.2% | +8.2% | |
| PE Ratio | 41.70 | -11.3% | +7.2% | +82.7% | +4.4% | |
| TTM Revenue | $24.57B | +1.2% | +2.9% | -18.8% | +10.3% | |
| TTM EPS | $5.05 | +4.0% | -4.5% | -47.5% | +3.6% | |
| TTM EBIT | $5.24B | -4.5% | +1.0% | -37.6% | +23.2% | |
| TTM Net Income | $3.60B | +2.8% | -7.7% | -48.5% | -1.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $7.90B | -2.7% | |
| 3Y | $10.52B | N/A | -27.0% |
| 5Y | $10.79B | -28.8% | |
| All | $10.79B | -28.8% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $7.52B | +2.2% | |
| 3Y | $7.10B | +8.2% | |
| 5Y | $6.03B | N/A | +27.5% |
| All | -$394.30M | +2049.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of DHR?
As of today, DHR TTM EBITDA is $7.69B
What is DHR TTM EBITDA most recent change?
DHR TTM EBITDA was down -2.73% on December 31, 2025
What is 1-year change in DHR TTM EBITDA?
DHR TTM EBITDA is up +1.98% year-over-year
How far is DHR TTM EBITDA from its all-time high?
DHR TTM EBITDA is currently -28.78% below its historical high of $10.79B set on September 30, 2022
How does DHR TTM EBITDA rank versus sector peers?
DHR TTM EBITDA is higher than 98.07% of companies in Healthcare sector
When is DHR next earnings release?
The next earnings release for DHR is on
EBITDA Formula
Data Sources & References
- DHR Official Website www.danaher.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/313616/000031361626000004/0000313616-26-000004-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/313616/000031361626000004/0000313616-26-000004-index.htm
- DHR Profile on Yahoo Finance finance.yahoo.com/quote/DHR
- DHR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dhr